Halozyme Therapeutics (HALO, $50.23) Moving Average Convergence Divergence (MACD) Histogram turned negative on May 13, 2025

#Biotechnology, #TechnicalAnalysis, #MACD, #Bearish, #Stocks, #MidCap, #Russel2000
HALO - Halozyme Therapeutics
MACD signal
Bearish Trend
76%
Odds of DOWN Trend
Price: $50.23
Daily change: -$16.35 (-24.56%)
Daily volume: 14M
Capitalization: $6.2B
Industry: Biotechnology

This is a Bearish indicator signaling HALO's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 41 similar cases where HALO's MACD histogram became negative, and 31 of them led to successful outcomes. Odds of Success: 76%.